Neozep

Quick links to important sections

Neozep

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neozep

Property Description
Active Ingredients Acetaminophen, Chlorphenamine Maleate, Phenylephrine Hydrochloride
Form Oral Solid Dosage (Tablet or Capsule)
Pharmacological Class Analgesic, Antipyretic, Antihistamine, Decongestant
Common Use Symptomatic relief of cold and flu discomforts
Origin Synthetic Chemical Combination

Neozep is formally classified as an over-the-counter (OTC) fixed-dose combination product designed for systemic use via the oral route of administration. As a widely recognized multi-symptom cold relief brand, it is positioned to treat the discomforts typically experienced by adults and adolescents. This combination approach is clinically recognized for effectively managing the key symptoms of upper respiratory illness.

The medication's identity is defined by its triple-action formula, featuring the three International Nonproprietary Names (INN): Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride. Each agent is included to address a specific facet of respiratory discomfort, ensuring comprehensive relief. Acetaminophen functions as an analgesic and antipyretic to relieve generalized body aches and reduce fever. Chlorphenamine Maleate, a first-generation H₁-receptor antagonist, curbs allergic symptoms such as sneezing and a runny nose. This agent is useful for alleviating the irritation caused by histamine release, which helps ease common allergy symptoms. The third component, Phenylephrine Hydrochloride, acts as a sympathomimetic agent which is responsible for clearing nasal passages by relieving congestion. The general purpose of this specific blend, therefore, is to deliver an integrated solution for the simultaneous management of pain, fever, allergic manifestations, and nasal stuffiness, providing broad symptomatic comfort during a typical cold or flu episode.

What side effects are possible with Neozep?

The official safety documentation for the fixed-dose combination of Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride details a range of possible adverse reactions across several physiological systems. These effects are classified by regulatory authorities to ensure clear communication of risks.

Documented Adverse Reactions

Side effects commonly listed in official labels include those related to the Nervous System and Psychiatric domains, such as drowsiness (somnolence), dizziness, insomnia, nervousness, and mild headache. Effects on the Gastrointestinal system may include dry mouth and constipation. The sympathomimetic component may contribute to Cardiac effects like palpitation and increased blood pressure, which are also documented in regulatory sources.

Serious Safety Considerations

Official labeling includes critical warnings for potentially serious adverse reactions. A primary constraint is the risk of Severe Liver Damage associated with the Acetaminophen component, particularly when exceeding the maximum recommended daily dose or when consumed concurrently with alcohol. Rare but severe Skin Reactions, such as blistering and rash, are also documented as a risk by regulatory authorities.

Safety Constraints and Populations

Regulatory documents outline specific safety constraints. Caution is advised for individuals with pre-existing conditions like high blood pressure, heart disease, diabetes, glaucoma, or trouble urinating due to an enlarged prostate gland. Furthermore, official notes indicate that side effects like dizziness and confusion may be more likely in older adults. The combination is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of a dangerous increase in blood pressure.

Overdose and Emergency Response

If you suspect an overdose of Neozep, it is critical to seek immediate medical attention or contact a poison control center right away, even if you feel well. Quick medical help is essential for adults and children due to the risk of serious, delayed harm.

Overdose Manifestations

Overdose symptoms are related to the active ingredients: Paracetamol, Phenylephrine, and Chlorphenamine Maleate.

  • Paracetamol (Acetaminophen): The primary concern is severe liver damage, which can progress to fatal liver failure. Toxicity often unfolds in four phases, beginning with non-specific symptoms like nausea, vomiting, and sweating, and progressing over several days to signs of liver failure, such as jaundice, right upper abdominal pain, and clotting problems.
  • Phenylephrine HCl: Overdose can affect the cardiovascular and nervous systems, potentially leading to significantly increased blood pressure, palpitation, seizures, headache, and in severe cases, cerebral hemorrhage.
  • Chlorphenamine Maleate: Symptoms affect the central nervous system and may include extreme or prolonged drowsiness, agitation, tachycardia, hallucination, convulsion, and coma.

Overdose Risk Factors

Severe liver damage risk is heightened if an adult takes more than the maximum recommended daily dose of Paracetamol or if this product is taken concurrently with other medicines containing Paracetamol (or Acetaminophen). Serious cardiovascular events, such as hypertensive crisis, may occur if this product is used alongside certain medicines for depression. Always consult a healthcare professional about all medicines being taken.

Therapeutic Uses of Neozep

The product is commonly used to provide symptomatic relief across domains where additional symptomatic support is needed during conditions associated with acute or disruptive episodes, such as the common cold and influenza. The product contributes to improved comfort during periods when symptoms become more noticeable. The combination is used to temporarily relieve these cold and flu symptoms.

The combination helps manage common symptoms such as body aches, headache, fever, nasal congestion, runny nose, and sneezing. The combination is applied in addressing these symptom clusters that may become intense or disruptive.

“The therapeutic aim is to offer supportive relief when symptoms may interfere with routine activities, which contributes to helping ease the overall symptom load.”


Managing Systemic Aches and Fever

This therapeutic domain is used for managing symptoms related to systemic imbalance by targeting mild to moderate headaches, body aches, and elevated fever. The core benefit is to help ease the overall physical distress, offering supportive relief that may assist with maintaining a sense of stability during periods when generalized discomfort and pain become more noticeable.

Quick Fact: Symptomatic Support for Multiple Symptom Axes


Alleviating Nasal Congestion and Blockage

The medication is applied in addressing supportive relief for symptoms related to nasal and sinus stuffiness and obstruction. This is relevant in contexts involving heightened systemic burden in the nasal membranes. By generally helping to clear passages, the treatment may assist with maintaining functional stability and is relevant for easing the discomfort that may interfere with breathing and contribute to functional strain.


Controlling Allergic-Type Irritation and Secretion

This cluster is applied when symptoms cluster into patterns requiring management of irritative phenomena like frequent sneezing and excessive runny nose (rhinorrhea). The benefit is commonly associated with helping to moderate these distressing manifestations, thereby contributing to easing the continuous irritation that disrupts general well-being and supports patients during episodes of heightened discomfort.

Regulatory References

  1. COLD MEDICINE- acetaminophen, chlorpheniramine maleate, phenylephrine hcl tablet

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The population eligibility for Neozep is strictly defined by regulatory authorities based on its three active ingredients. The medicine is typically approved for use by adults and adolescents (12 years of age and older).

Absolute Contraindications

Regulatory labels state that the medicine must not be used by specific populations. Use is contraindicated in patients with known hypersensitivity to any component. It is also contraindicated for patients currently taking or who have stopped Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days.

Formal exclusions include individuals with severe hypertension, severe coronary artery disease, or severe hepatic (liver) impairment. Use is generally contraindicated or not recommended in pregnant and breastfeeding women.

Age and Condition Restrictions

The standard oral formulation is not recommended for children under 12 years and is formally contraindicated for children under 4 years of age. Caution is required for older adults and for patients with conditions such as mild-to-moderate hypertension, diabetes mellitus, hyperthyroidism, closed-angle glaucoma, and non-severe renal impairment, as documented in official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines specific substance categories and agents that require strict restriction or monitoring due to potential interaction risks with the product’s components (Acetaminophen, Chlorphenamine, Phenylephrine).

Contraindicated Combinations and Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated; a mandatory 14-day separation period is required after discontinuing the MAOI. It is also prohibited to combine this product with any other prescription or nonprescription medicine containing acetaminophen due to the serious, documented risk of liver damage.

Pharmacodynamic and Metabolic Interactions

Concomitant use with alcohol or other CNS depressants (including sedatives or opioids) results in additive reinforcement of sedation and drowsiness. Additive effects also occur with other anticholinergic agents. The Phenylephrine component’s pressor activity can be intensified by other sympathomimetic agents, raising the potential for cardiovascular consequences. The Acetaminophen component has been documented to interact with Warfarin, potentially increasing the International Normalized Ratio (INR). Additionally, the Chlorphenamine component may inhibit the metabolism of Phenytoin, which can result in increased plasma exposure of Phenytoin. Chronic, excessive consumption of alcohol is formally noted to heighten the risk of severe hepatotoxicity from the acetaminophen content. Elderly or debilitated patients are documented to have increased sensitivity to the product's CNS depressant and anticholinergic effects.

Mechanism of Action

How Neozep Works

This combination product modulates physiological processes through the distinct actions of its components at specific biological targets.

Pharmacodynamic Mechanism

Phenylephrine functions as a direct-acting alpha1-adrenergic receptor agonist. This receptor interaction triggers an intracellular cascade resulting in the vasoconstriction of arterioles within the nasal and sinus microvasculature. The resultant physiological consequence is a reduction in local blood flow and capillary permeability, which modulates tissue fluid volume.

Chlorphenamine acts as an antagonist at the histamine H1 receptor. By competitively binding to the H1 receptor, it prevents the action of endogenous histamine, thereby inhibiting the cascade of vasodilation and increased vascular permeability in submucosal tissue.

Paracetamol modulates the synthesis of lipid mediators by inhibiting cyclooxygenase ( COX) activity, primarily COX-2, within the central nervous system. This molecular activity restricts the formation of prostaglandins E2 ( PGE2), which are key mediators in hypothalamic thermoregulation and nociception. The systemic physiological consequence is the modulation of the central thermal setpoint and the interruption of afferent pain signal transmission.

Dosage and Administration Information

The fixed-dose combination product containing Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride is standardized for oral administration using a tablet or caplet dosage form. Usage for adults and adolescents 12 years and older requires a standard single dose to be taken every 4 to 6 hours as required.


Administration Protocol

Feature Standard Instruction
Route & Form Oral; must be swallowed whole, not crushed or chewed.
Dosing Frequency Every 4 to 6 hours, as needed.
Maximum Dose Must not exceed 4,000 mg of Acetaminophen in 24 hours.
Meal Relationship May be taken with or without food.
Duration Limit Use is temporary; stop if symptoms do not improve within 7 days or if fever persists past 3 days.

The tablet or caplet must be swallowed whole to ensure proper administration. A critical restriction is the Non-Interference Rule, which mandates that the product must not be taken with any other medicine containing Acetaminophen (Paracetamol) to prevent unintended overdose. For children under 12 years of age, the instruction is to "ask a doctor" before administration. If a dose is missed, the protocol is to take the next dose only at the regularly scheduled time, if still needed, and not to double the dose. These instructions establish the formal, short-term protocol for administration.

Recent Clinical Evidence

Evidence for Symptom Management During the Common Cold

Research has primarily focused on the fixed-dose combination (Acetaminophen, Chlorphenamine Maleate, and Phenylephrine Hydrochloride) for conditions associated with acute or disruptive episodes like the common cold and flu-like syndrome. The core evidence stems from short-term Randomized Controlled Trials (RCTs) that study the combination alongside a placebo over defined time intervals, typically 2 to 5 days. These trials research examined outcomes related to physiological strain or stress, such as patient-reported severity of fever, headache, and nasal issues, using composite Total Symptom Scores (TSS).

Studies conducted during periods of increased symptom activity monitored changes in these scores. Findings describe patterns observed in the studies, particularly concerning the initial days of treatment, and evidence provides insight into short-term changes across various symptoms and how they evolved in the observed populations. However, evidence quality varies across studies for the decongestant component (Phenylephrine), where findings were mixed in some scientific literature regarding its effectiveness as an oral nasal decongestant. The evidence available focuses on outcomes related to physical discomfort over a brief period.


Evidence in Different Patient Groups and Research Gaps

The majority of the evidence and the research base are centered on studies of Adults (ages 18 to 60) who were otherwise generally healthy. The evidence record also includes data relevant to Adolescents (12 years and older). Data for certain groups remain insufficient, with few dedicated data available for older adults (over 65) or individuals with complex health conditions (comorbidities). Some post-marketing studies have included observations on children (ages 2 to 12).

Long-term effects are not fully established, as follow-up durations in primary trials were limited. Certainty remains low regarding outcomes that are not captured by the acute Total Symptom Score measurements. A key research limitation is that the results apply only to the populations studied, and findings describe group patterns, not personal outcomes. The effect of the combination on outcomes related to systemic or functional imbalance after the treatment period remains largely unstudied.

Key Studies & References

  1. Efficacy and safety of paracetamol, phenylephrine, chlorpheniramine maleate and sodium citrate in Indian paediatric patients of common cold: an active post marketing surveillance study
  2. Label: ALLERGY MULTI-SYMPTOM - acetaminophen, chlorpheniramine maleate and phenylephrine hcl tablet, film coated (Example DailyMed label for combination product ingredients and uses)

Frequently Asked Questions (FAQ)

Common questions about Neozep (FAQ)


Q: Is Neozep the same as other common cold medicines, and if not, what is the main difference?

Neozep is described in official product information as a multi-component product that features ingredients from three different pharmacological classes: an analgesic/fever reducer, a decongestant, and an antihistamine. Other cold medicines may use a different blend or fewer active ingredients.


Q: What are the different versions of Neozep available?

Official regulatory documents mention that different variants may be available that feature different combinations of active ingredients. Examples include Neozep Forte (the full triple combination) and Neozep Non-Drowsy (a double combination, typically without Chlorphenamine Maleate).


Q: Is there a version of Neozep that is described as 'non-drowsy'?

Yes, official product information describes a variant called Neozep Non-Drowsy. This formulation generally contains the decongestant and pain reliever components but excludes the sedating antihistamine component (Chlorphenamine Maleate).


Q: What are the different active ingredients found in the Neozep Forte version?

According to the official product information, the active ingredients for the Neozep Forte variant are the triple combination of Phenylephrine Hydrochloride, Chlorphenamine Maleate, and Paracetamol (Acetaminophen).


Q: Is there a difference in ingredients between Neozep Forte and Neozep Non-Drowsy?

The primary difference is that the Neozep Non-Drowsy variant typically does not contain Chlorphenamine Maleate, the antihistamine component known to cause drowsiness, while the Forte variant does.


Q: What is the significance of the Neozep variant that contains Paracetamol but not Chlorphenamine Maleate?

This variant combines the fever-reducing and pain-relieving action of Paracetamol with the decongestant action of Phenylephrine. The significance is that it provides symptomatic relief without the potential for sedating effects associated with the Chlorphenamine Maleate component, making it suitable as a non-drowsy option.


Q: Is Neozep commonly used for symptoms related to the flu?

The indications for the medicine include the relief of various symptoms such as fever, body pain, and headache that are associated with both the common cold and flu-like syndrome.


Q: Why is Neozep described as being used for 'postnasal drip'?

One of the medicine's active components, Phenylephrine, which functions as a nasal decongestant, is documented in product information as contributing to the reduction of postnasal drip by reducing swelling in the nasal passages.


Q: Do studies support the combination of ingredients used in Neozep?

Research findings describe a pattern where the combination showed greater changes in Total Symptom Scores compared to placebo in reducing the severity of symptoms related to the common cold over a short period of time.


Q: Is there evidence that Neozep shortens the duration of cold symptoms?

Research focuses on short-term relief, and findings describe patterns where studied patients experienced reduction in symptom severity typically between the third and fifth day of treatment. The evidence does not formally claim to shorten the natural course of the cold.


Q: How quickly can a person typically expect Neozep to start working?

Each active component in the medicine is absorbed at a different rate. Pharmacokinetic data suggests that the Paracetamol component may reach its highest concentration in the blood within approximately 10 to 60 minutes after taking the dose, and the decongestant component may reach its highest concentration in roughly one to one-and-a-half hours.


Q: What are the general expectations about the duration of action for Neozep?

Official dosing information describes a frequency interval of every four to six hours, as required. Information available for the components indicates that a duration of effect lasting approximately four to six hours has been reported for some of the active substances.


Q: Is it possible for Neozep to cause sleepiness or drowsiness?

Yes, official safety documents list drowsiness and somnolence among the commonly reported adverse reactions associated with the medicine's use, particularly as the standard formulation contains the sedating antihistamine component.


Q: Are there other specific side effects to be aware of beyond drowsiness, such as tremors or anxiety?

Adverse reactions noted in official documents include effects on the nervous system such as anxiety, nervousness, restlessness, and muscle shaking (tremor).


Q: What types of side effects are sometimes categorized as 'minor stomach and intestinal disturbances'?

The documented minor stomach and intestinal disturbances associated with the components of the medicine may include symptoms such as abdominal pain, cramps, nausea, vomiting, or general gastrointestinal discomfort or irritation.


Q: What kind of symptoms are sometimes seen if a person takes more Neozep than described in official documents (overdosage information)?

Official documentation describes a serious, documented risk of liver damage associated with the Acetaminophen component in addition to other symptoms that may occur. Acute overdose may be associated with symptoms like nausea, vomiting, sweating, confusion, hallucinations, severe nervousness, rapid pulse, and high blood pressure.


Q: Is there information on the safety profile of Neozep for people who are pregnant or breastfeeding?

Official regulatory documents generally advise caution and state that the product is contraindicated or not recommended for use by pregnant or breastfeeding women, primarily due to limited data and potential risks associated with its components.


Q: Can a person with asthma or other respiratory distress conditions use Neozep?

Official warnings indicate that the medicine is generally not recommended for individuals currently experiencing respiratory distress and advise caution for patients with pre-existing conditions like asthma.


Q: Can Neozep potentially interact with common antidepressants like MAOIs or tricyclic antidepressants (TCAs)?

The use of the medicine is formally contraindicated with Monoamine Oxidase Inhibitors (MAOIs). The Phenylephrine and Chlorphenamine components may also have documented interactions with Tricyclic Antidepressants (TCAs), which may reinforce side effects like drowsiness or affect blood pressure.


Q: Does Neozep contain any ingredients that may interact with certain high blood pressure medications?

The Phenylephrine component has pressor activity, and official documents advise caution regarding co-administration with certain medicines used to treat high blood pressure.


Q: Is there any known caution related to using Neozep with other decongestants?

Official drug interaction information warns that the pressor effects of the Phenylephrine component can be intensified if co-administered with other sympathomimetic agents. This class of agents includes many other types of decongestants.


Q: Does the package insert mention any specific food interactions with Neozep?

Official documents state the medicine may be taken with or without food. However, the Phenylephrine component has been noted to potentially interact with high amounts of caffeine-containing foods or beverages, which may intensify side effects such as nervousness or palpitations.


Q: Do official documents recommend avoiding taking other supplements or medicines that contain zinc while using the Neozep Z+ variant?

Official product information for the zinc-containing variant notes that additive effects are possible with the concurrent administration of zinc and certain other medicines, advising caution when combining them.

How should Neozep be stored and disposed of?

How to Store and Dispose of Neozep

Official regulatory information requires that this medicine be stored under specific environmental conditions to maintain its integrity and potency.

Storage Requirements

Neozep must be kept out of the reach and sight of children as a mandatory safety measure. The product is required to be stored at room temperature—typically between 20 C and 25 C (68 F and 77 F), with temperatures not exceeding 30 C.

It is essential to protect the medicine from moisture and excessive heat and to keep it in the original container until the date of expiration.

Disposal Instructions

Unused or expired Neozep should be discarded using a formal drug take-back program if one is available. If a take-back program is not accessible, the product can be disposed of in the household trash by first mixing the medicine with an undesirable substance (such as used coffee grounds or cat litter) and then placing the mixture in a sealed container before disposal. All identifying information on the original label should be scratched out to protect privacy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neozep found in:

A-Z Index: